Document is current
Any future updates will be listed below
-
Authors
Altshuller, Maria
He, Xu
MacKrell, Elliot J.
Wernke, Kevin M.
Airan, Yougant https://orcid.org/0009-0002-8047-2659
Wong, Joel W. H.
Sellés-Baiget, Selene
Wang, Ting-Yu
Chou, Tsui-Fen https://orcid.org/0000-0003-2410-2186
Duxin, Julien P. https://orcid.org/0000-0001-9389-4186
Balskus, Emily P. https://orcid.org/0000-0001-5985-5714
Herzon, Seth B. https://orcid.org/0000-0001-5940-9853
Semlow, Daniel R. https://orcid.org/0000-0001-6538-9713
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01GM151410, R01CA208834)
Novo Nordisk Fonden (NNF14CC0001, NNF220C0074140)
- License Information
-
More Information
Article History
Received: 4 November 2024
Accepted: 17 October 2025
First Online: 26 November 2025
Competing interests
: E.P.B. is an inventor on the following patents related to detection and inhibition of colibactin biosynthesis: U.S. Patent 11,617,759, U.S. Patent 12,115,176, and U.S. Patent 11,040,951. All other authors have no competing interests to declare.
